Renal and MetabolicCVRMdiseases.Use of termsIn this Annual Report,unless the context otherwise requires,AstraZeneca,the Group,we,us and our refer to AstraZeneca PLC and its consolidated entities.Welcome zDenotes a scale break.Throughout this Annual Report,all bar chart scales start from zero.We ...
AstraZeneca plc. Tezspire approved in the EU for the treatment of severe asthma. 2022. Available at: https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2022/tezspire-approved-in-the-eu-for-the-treat...
Astrazeneca Plc (AZN) financials statements overview reports - Astrazeneca Plc's market cap is currently ―. The company's EPS TTM is $2.1; its P/E ratio is 32.5, and it has a dividend yield of 2.13%.
6 项与Astrazeneca Plc /Longmont Manufacturing Operations/ 相关的新闻(医药) 2024-04-20 ·药智网 百亿吸入制剂市场的突围 作为慢性阻塞性肺病和哮喘的一线疗法,全球吸入制剂市场呈现一片欣欣向荣之景。从市场规模来看,2018-2023年全球吸入制剂销售额复合增长率为2.68%;2023年销售额同比增长6.17%,接近3500亿元。
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
AstraZeneca Plc Share EquityWhat's this? Price(GBX) 10,524.000.53%(56.00) AZNORD SHS $0.25 Track6 more instruments Open/Last close 10,520.00/10,524.00 High/Low 10,606.00/10,482.00 Bid/Offer 10,522.00/10,524.00 Special Condition:-
AstraZeneca PLC (AZN) has a Smart Score of 10 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
Cash Flows for Astrazeneca Plc ADR (AZN) from Operating Activities, Investing Activities, Financing Activities.
AstraZeneca is commencing today, through a subsidiary, a tender offer to purchase all outstanding shares of CinCor Pharma, Inc. (CinCor), for $26 per share in cash at closing, plus a non-tradable contingent value right of $10 per share in cash payable up
David and Tom just revealed what they believe are theten best stocksfor investors to buy right now... and AstraZeneca PLC wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks